Scilex Holding Co(SCLX)Stock Analysis

SCLX Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Scilex Holding Co (SCLX), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SCLX at 20.5/100 on a 32-signal composite quality model, placing it at rank #2,672 of 2,879 stocks — the bottom half of the AI-ranked universe. SCLX scores in the top quartile across free cash flow (94.2). Areas of concern include balance sheet strength (0.7) and profitability (2.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 4.6/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Scilex Holding Co reports quarterly revenue of $8.6M, net income of $-45.6M, free cash flow of $-1.1M. Top institutional holders of SCLX by reported 13-F value include ARMISTICE CAPITAL,, VANGUARD CAPITAL MANAGEMENT, BlackRock,, based on the most recent SEC filings. SCLX trades on the Nasdaq exchange and files with the SEC under CIK 1820190. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SCLX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Scilex Holding Co directly from SEC EDGAR.